Asymmetry Ventures | Activity | F4

Introducing F4 Champions, a new accelerator for founders at the earliest stage.F4 Champions for early-stage foundersEnrollment closesAugust 2Learn more

Team Portfolio Raise Champions Essays

F4/Asymmetry Ventures/Activity

Asymmetry Ventures Activity

Every public signal F4 has attached to this firm, with sources and cross-entity links.

Types

Time range

Milestone

Portfolio company TYBR Health closed a $30M Series A led by Vensana Capital and Mutual Capital Partners to expand access to its FDA-cleared B3 GEL System.

TYBR Health

TYBR Health Asymmetry Ventures

prnewswire.comJUL 21, 2026

JUL 21, 2026

Investment

Invested in Enlightra's $15M Series A for AI/quantum optical interconnects and energy-efficient data center lasers.

Enlightra

Enlightra Asymmetry Ventures

nordic9.comDEC 18, 2025

thequantuminsider.com

thequantuminsider.com

DEC 18, 2025

Milestone

Portfolio company TYBR Health received FDA 510(k) clearance for its B3 GEL System, a bioresorbable gel that protects healing tissue during surgical recovery.

TYBR Health

TYBR Health Asymmetry Ventures

biospace.comJUN 9, 2025

JUN 9, 2025

Investment

Co-invested in PERSIST.AI's $12M Series A for AI-driven robotic pharmaceutical formulation development.

PERSIST.AI

PERSIST.AI Asymmetry Ventures

prnewswire.comMAY 19, 2025

MAY 19, 2025

Investment

Participated in Coreshell's $24M Series A2 round for domestically-sourced silicon battery anodes for EVs.

Coreshell

Coreshell Asymmetry Ventures

techcrunch.comMAR 18, 2025

MAR 18, 2025

Exit

Portfolio company Atomic Alchemy was acquired by Oklo for $25M to expand radioisotope production and supply chain.

Atomic Alchemy

Atomic Alchemy Asymmetry Ventures

businesswire.comMAR 2025

MAR 2025